Cytomx therapeutics inc.

Major-Pharmaceuticals

CTMX


151 Oyster Point Boulevard
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 1.16
    $ +0.02 1.32 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.74 - $1.07
  • YTD
  • -25.5%

  • Trading Volume
  • 11,862
  • Market Cap Full
  • $ 77.7M
  • Shares Outstanding
  • 67M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -38.2% 57.1% 34.8% -28.8% -5% 18% -37.4% -5.6% 40.7%
Q2 - -20.8% -10.3% -18.1% 0.4% 4% -18.1% -32.5% 13.9% -0.5%
Q3 - 53.4% 17.2% -21.6% -32% 8% -19.6% -20.8% -25% -
Q4 61.8% -29.9% 9.7% -18.9% 12.8% -1.5% -14.9% 10.3% 24% -
J F M A M J J A S O N D
2024 -1.3% 60.1% -11% -1.8% - - - - - - - -
2023 68.8% -20.4% -29.8% 8% 4.9% 0.6% 1.2% -13.8% -14% -14.7% 26.4% 11.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-47%92%-28%-44%-22%-34%-63%-3%-25%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.44 0.23 -0.4 -0.31 0.26 -0.26 -0.37 -0.05
Q2 - 0.39 0.69 -0.35 -0.64 -0.34 -0.3 -0.37 -0.02
Q3 14.26 0.40 0.28 -0.53 -0.52 -0.32 -0.35 -0.35 0.04
Q4 0.39 0.39 0.02 -0.75 -0.79 -0.31 -0.9 -0.42 -
A 14.7 1.6 1.2 -2 -2.3 -0.7 -1.8 -1.5 -0.03

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 45.1 45.6 64.8 65.4 66.2
Jun 39 45.3 45.9 65 65.4 66.3
Sep 45 45.4 46.2 65.2 66 66.8
Dec 45 45.4 46.2 65.2 66.1 67

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 8.8 8.8 10 5.7 6.7
Total Asset Turnover 0.2 0.2 0.3 0.2 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 50.5 - 3.1 12.3 -11.1
Equity multiplier -0.1 0.1 0.2 0.2 0.1